Controlling Insects - Oxitec
(Isis - 992)
Based on technology developed by molecular biologist Dr Luke Alphey and colleagues at Oxford University's Department of Zoology, Oxitec aims to reduce the size of insect populations responsible for causing disease and destroying crops.
Oxitec Limited was spun out by Isis in 2002, with investment from East Hill Advisors LLC of Boston, the University of Oxford (through the Isis College Fund), and later Oxford Capital Partners. It remains located in Oxford.
Oxitec aims to be a world leader in the field of biological insect pest control by developing and introducing technology to improve the well-established Sterile Insect Technique (SIT). Potential improvements include enhanced effectiveness, reduced cost, a wider range of applications, and reduced environmental impact of this already very environment-friendly approach.
Oxitec’s technology will have a significant beneficial impact on both agriculture and public health and will be a valuable tool in integrated pest management programs. Oxitec has generated product candidates for four insect pest control markets, and has advanced its lead candidate to the final testing phase of the development pathway in the USA.
The company’s approach to insect control was recognised by the Bill and Melinda Gates Foundation Grand Challenges for Global Health Initiative with an award as part of a $20 million consortium developing genetic strategies to control disease-carrying mosquitoes.
Lead Researchers: Dr Luke Alphey
University Department: Department of Zoology
Date of Disclosure to Isis: 1999
University Challenge Seed Fund (UCSF) Support: £228,775
Isis News